WO2003090684A3 - Polymer compositions containing a macrocyclic triene compound - Google Patents
Polymer compositions containing a macrocyclic triene compound Download PDFInfo
- Publication number
- WO2003090684A3 WO2003090684A3 PCT/US2003/012746 US0312746W WO03090684A3 WO 2003090684 A3 WO2003090684 A3 WO 2003090684A3 US 0312746 W US0312746 W US 0312746W WO 03090684 A3 WO03090684 A3 WO 03090684A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- triene compound
- macrocyclic triene
- compositions containing
- polymer compositions
- polymer composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/022—Metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/072—Encapsulated stents, e.g. wire or whole stent embedded in lining
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91575—Adjacent bands being connected to each other connected peak to trough
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/0054—V-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2240/001—Designing or manufacturing processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/08—Coatings comprising two or more layers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Surgery (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Materials For Medical Uses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Prostheses (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003587323A JP4315817B2 (en) | 2002-04-24 | 2003-04-24 | Polymer composition comprising macrocyclic triene compound |
AU2003231757A AU2003231757B2 (en) | 2002-04-24 | 2003-04-24 | Polymer compositions containing a macrocyclic triene compound |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/133,814 US6939376B2 (en) | 2001-11-05 | 2002-04-24 | Drug-delivery endovascular stent and method for treating restenosis |
US10/133,814 | 2002-04-24 |
Publications (4)
Publication Number | Publication Date |
---|---|
WO2003090684A2 WO2003090684A2 (en) | 2003-11-06 |
WO2003090684A3 true WO2003090684A3 (en) | 2004-02-26 |
WO2003090684B1 WO2003090684B1 (en) | 2004-05-13 |
WO2003090684A8 WO2003090684A8 (en) | 2004-12-16 |
Family
ID=29268785
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/012746 WO2003090684A2 (en) | 2002-04-24 | 2003-04-24 | Polymer compositions containing a macrocyclic triene compound |
PCT/US2003/012750 WO2003090818A2 (en) | 2002-04-24 | 2003-04-24 | Drug-delivery endovascular stent and method for treating restenosis |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/012750 WO2003090818A2 (en) | 2002-04-24 | 2003-04-24 | Drug-delivery endovascular stent and method for treating restenosis |
Country Status (10)
Country | Link |
---|---|
US (6) | US6939376B2 (en) |
EP (6) | EP2316377B1 (en) |
JP (6) | JP4315817B2 (en) |
CN (3) | CN101862233B (en) |
AT (1) | ATE451075T1 (en) |
AU (3) | AU2003231759B2 (en) |
DE (1) | DE60330455D1 (en) |
ES (4) | ES2522277T3 (en) |
HK (3) | HK1177882A1 (en) |
WO (2) | WO2003090684A2 (en) |
Families Citing this family (369)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2178541C (en) | 1995-06-07 | 2009-11-24 | Neal E. Fearnot | Implantable medical device |
US7208010B2 (en) | 2000-10-16 | 2007-04-24 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
US7208011B2 (en) * | 2001-08-20 | 2007-04-24 | Conor Medsystems, Inc. | Implantable medical device with drug filled holes |
US6241762B1 (en) | 1998-03-30 | 2001-06-05 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
US7713297B2 (en) | 1998-04-11 | 2010-05-11 | Boston Scientific Scimed, Inc. | Drug-releasing stent with ceramic-containing layer |
US6790228B2 (en) | 1999-12-23 | 2004-09-14 | Advanced Cardiovascular Systems, Inc. | Coating for implantable devices and a method of forming the same |
US6908624B2 (en) * | 1999-12-23 | 2005-06-21 | Advanced Cardiovascular Systems, Inc. | Coating for implantable devices and a method of forming the same |
US20050238686A1 (en) * | 1999-12-23 | 2005-10-27 | Advanced Cardiovascular Systems, Inc. | Coating for implantable devices and a method of forming the same |
US7419678B2 (en) * | 2000-05-12 | 2008-09-02 | Cordis Corporation | Coated medical devices for the prevention and treatment of vascular disease |
US7175658B1 (en) * | 2000-07-20 | 2007-02-13 | Multi-Gene Vascular Systems Ltd. | Artificial vascular grafts, their construction and use |
HUP0300810A2 (en) | 2000-07-20 | 2003-08-28 | M.G.V.S. Ltd. | Artifical vascular grafts, and methods of producing and using same |
ATE387169T1 (en) | 2000-10-16 | 2008-03-15 | Conor Medsystems Inc | EXPANDABLE MEDICAL DEVICE FOR DELIVERING A MEDICINE |
EP1258230A3 (en) * | 2001-03-29 | 2003-12-10 | CardioSafe Ltd | Balloon catheter device |
US6764505B1 (en) | 2001-04-12 | 2004-07-20 | Advanced Cardiovascular Systems, Inc. | Variable surface area stent |
US8741378B1 (en) | 2001-06-27 | 2014-06-03 | Advanced Cardiovascular Systems, Inc. | Methods of coating an implantable device |
US7247313B2 (en) * | 2001-06-27 | 2007-07-24 | Advanced Cardiovascular Systems, Inc. | Polyacrylates coatings for implantable medical devices |
US7842083B2 (en) | 2001-08-20 | 2010-11-30 | Innovational Holdings, Llc. | Expandable medical device with improved spatial distribution |
US7056338B2 (en) * | 2003-03-28 | 2006-06-06 | Conor Medsystems, Inc. | Therapeutic agent delivery device with controlled therapeutic agent release rates |
GB0121980D0 (en) | 2001-09-11 | 2001-10-31 | Cathnet Science Holding As | Expandable stent |
US20030077310A1 (en) | 2001-10-22 | 2003-04-24 | Chandrashekhar Pathak | Stent coatings containing HMG-CoA reductase inhibitors |
US6939376B2 (en) | 2001-11-05 | 2005-09-06 | Sun Biomedical, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
US7682387B2 (en) * | 2002-04-24 | 2010-03-23 | Biosensors International Group, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
US7182779B2 (en) | 2001-12-03 | 2007-02-27 | Xtent, Inc. | Apparatus and methods for positioning prostheses for deployment from a catheter |
US20030135266A1 (en) * | 2001-12-03 | 2003-07-17 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US7351255B2 (en) * | 2001-12-03 | 2008-04-01 | Xtent, Inc. | Stent delivery apparatus and method |
US7892273B2 (en) | 2001-12-03 | 2011-02-22 | Xtent, Inc. | Custom length stent apparatus |
US20040186551A1 (en) * | 2003-01-17 | 2004-09-23 | Xtent, Inc. | Multiple independent nested stent structures and methods for their preparation and deployment |
US7294146B2 (en) | 2001-12-03 | 2007-11-13 | Xtent, Inc. | Apparatus and methods for delivery of variable length stents |
US8080048B2 (en) | 2001-12-03 | 2011-12-20 | Xtent, Inc. | Stent delivery for bifurcated vessels |
US7270668B2 (en) * | 2001-12-03 | 2007-09-18 | Xtent, Inc. | Apparatus and methods for delivering coiled prostheses |
US7309350B2 (en) | 2001-12-03 | 2007-12-18 | Xtent, Inc. | Apparatus and methods for deployment of vascular prostheses |
US7137993B2 (en) | 2001-12-03 | 2006-11-21 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US7147656B2 (en) | 2001-12-03 | 2006-12-12 | Xtent, Inc. | Apparatus and methods for delivery of braided prostheses |
US20040024450A1 (en) * | 2002-04-24 | 2004-02-05 | Sun Biomedical, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
US6645547B1 (en) * | 2002-05-02 | 2003-11-11 | Labcoat Ltd. | Stent coating device |
US7270675B2 (en) * | 2002-05-10 | 2007-09-18 | Cordis Corporation | Method of forming a tubular membrane on a structural frame |
JP2005531391A (en) * | 2002-06-27 | 2005-10-20 | 微創医療器械(上海)有限公司 | Drug release stent |
PT1539157E (en) | 2002-09-18 | 2013-10-04 | Univ Pennsylvania | Rapamycin for use in inhibiting or preventing choroidal neovascularization |
US8303511B2 (en) | 2002-09-26 | 2012-11-06 | Pacesetter, Inc. | Implantable pressure transducer system optimized for reduced thrombosis effect |
US7149587B2 (en) | 2002-09-26 | 2006-12-12 | Pacesetter, Inc. | Cardiovascular anchoring device and method of deploying same |
US6971813B2 (en) * | 2002-09-27 | 2005-12-06 | Labcoat, Ltd. | Contact coating of prostheses |
AU2003301246A1 (en) * | 2002-10-15 | 2004-05-04 | Norbert Thompson | Parylene-coated silicone t-tubes and method of use thereof |
WO2004043509A1 (en) * | 2002-11-08 | 2004-05-27 | Conor Medsystems, Inc. | Expandable medical device and method for treating chronic total occlusions with local delivery of an angiogenic factor |
US7169178B1 (en) * | 2002-11-12 | 2007-01-30 | Advanced Cardiovascular Systems, Inc. | Stent with drug coating |
US20060121080A1 (en) * | 2002-11-13 | 2006-06-08 | Lye Whye K | Medical devices having nanoporous layers and methods for making the same |
US9770349B2 (en) * | 2002-11-13 | 2017-09-26 | University Of Virginia Patent Foundation | Nanoporous stents with enhanced cellular adhesion and reduced neointimal formation |
JP2006514848A (en) * | 2002-11-13 | 2006-05-18 | セタゴン インコーポレーティッド | Medical device having porous layer and method for producing the same |
US20050070989A1 (en) * | 2002-11-13 | 2005-03-31 | Whye-Kei Lye | Medical devices having porous layers and methods for making the same |
US8435550B2 (en) | 2002-12-16 | 2013-05-07 | Abbot Cardiovascular Systems Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
US7758881B2 (en) | 2004-06-30 | 2010-07-20 | Advanced Cardiovascular Systems, Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
US20060002968A1 (en) * | 2004-06-30 | 2006-01-05 | Gordon Stewart | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders |
US8715771B2 (en) * | 2003-02-26 | 2014-05-06 | Abbott Cardiovascular Systems Inc. | Coated stent and method of making the same |
US20090093875A1 (en) | 2007-05-01 | 2009-04-09 | Abbott Laboratories | Drug eluting stents with prolonged local elution profiles with high local concentrations and low systemic concentrations |
EP1605863B1 (en) | 2003-03-14 | 2016-09-07 | Intersect ENT, Inc. | Sinus delivery of sustained release therapeutics |
US20040202692A1 (en) * | 2003-03-28 | 2004-10-14 | Conor Medsystems, Inc. | Implantable medical device and method for in situ selective modulation of agent delivery |
EP1610823B1 (en) | 2003-03-28 | 2011-09-28 | Innovational Holdings, LLC | Implantable medical device with continuous agent concentration gradient |
US7241308B2 (en) * | 2003-06-09 | 2007-07-10 | Xtent, Inc. | Stent deployment systems and methods |
US7229979B2 (en) * | 2003-06-23 | 2007-06-12 | Immune Modulation, Inc. | Hypoestoxides, derivatives and agonists thereof for use as stent-coating agents |
US20050118344A1 (en) | 2003-12-01 | 2005-06-02 | Pacetti Stephen D. | Temperature controlled crimping |
US6840569B1 (en) * | 2003-07-22 | 2005-01-11 | Arthur Donald Leigh | Caravan |
US20050043786A1 (en) * | 2003-08-18 | 2005-02-24 | Medtronic Ave, Inc. | Methods and apparatus for treatment of aneurysmal tissue |
US20050049693A1 (en) * | 2003-08-25 | 2005-03-03 | Medtronic Vascular Inc. | Medical devices and compositions for delivering biophosphonates to anatomical sites at risk for vascular disease |
US20050048194A1 (en) * | 2003-09-02 | 2005-03-03 | Labcoat Ltd. | Prosthesis coating decision support system |
US20050058768A1 (en) * | 2003-09-16 | 2005-03-17 | Eyal Teichman | Method for coating prosthetic stents |
US20050080475A1 (en) * | 2003-10-14 | 2005-04-14 | Xtent, Inc. A Delaware Corporation | Stent delivery devices and methods |
JP2007508121A (en) * | 2003-10-14 | 2007-04-05 | キューブ メディカル エーエス | Angioplasty balloon |
US7553324B2 (en) * | 2003-10-14 | 2009-06-30 | Xtent, Inc. | Fixed stent delivery devices and methods |
US7192440B2 (en) * | 2003-10-15 | 2007-03-20 | Xtent, Inc. | Implantable stent delivery devices and methods |
US20050100577A1 (en) * | 2003-11-10 | 2005-05-12 | Parker Theodore L. | Expandable medical device with beneficial agent matrix formed by a multi solvent system |
US7220755B2 (en) | 2003-11-12 | 2007-05-22 | Biosensors International Group, Ltd. | 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same |
US7403966B2 (en) * | 2003-12-08 | 2008-07-22 | Freescale Semiconductor, Inc. | Hardware for performing an arithmetic function |
US7326236B2 (en) | 2003-12-23 | 2008-02-05 | Xtent, Inc. | Devices and methods for controlling and indicating the length of an interventional element |
US20070156225A1 (en) * | 2003-12-23 | 2007-07-05 | Xtent, Inc. | Automated control mechanisms and methods for custom length stent apparatus |
WO2005068020A1 (en) | 2004-01-02 | 2005-07-28 | Advanced Cardiovascular Systems, Inc. | High-density lipoprotein coated medical devices |
DE102004029611A1 (en) * | 2004-02-06 | 2005-08-25 | Restate Patent Ag | Implant for e.g. releasing active substances into a vessel through which body fluids flow, comprises a base consisting of a biodegradable material as the carrier of the active substances |
ES2632124T3 (en) * | 2004-02-28 | 2017-09-11 | Hemoteq Ag | Biocompatible coating, method and use of medical surfaces |
EP1571151B1 (en) * | 2004-03-01 | 2008-12-24 | Terumo Kabushiki Kaisha | Process for production of O-alkylated rapamycin derivatives |
US7695731B2 (en) * | 2004-03-22 | 2010-04-13 | Cordis Corporation | Local vascular delivery of etoposide in combination with rapamycin to prevent restenosis following vascular injury |
US7323006B2 (en) | 2004-03-30 | 2008-01-29 | Xtent, Inc. | Rapid exchange interventional devices and methods |
US8778014B1 (en) | 2004-03-31 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Coatings for preventing balloon damage to polymer coated stents |
US20050228477A1 (en) * | 2004-04-09 | 2005-10-13 | Xtent, Inc. | Topographic coatings and coating methods for medical devices |
US8024036B2 (en) | 2007-03-19 | 2011-09-20 | The Invention Science Fund I, Llc | Lumen-traveling biological interface device and method of use |
US7998060B2 (en) | 2004-04-19 | 2011-08-16 | The Invention Science Fund I, Llc | Lumen-traveling delivery device |
US8337482B2 (en) | 2004-04-19 | 2012-12-25 | The Invention Science Fund I, Llc | System for perfusion management |
US8092549B2 (en) | 2004-09-24 | 2012-01-10 | The Invention Science Fund I, Llc | Ciliated stent-like-system |
US9011329B2 (en) | 2004-04-19 | 2015-04-21 | Searete Llc | Lumenally-active device |
US7850676B2 (en) | 2004-04-19 | 2010-12-14 | The Invention Science Fund I, Llc | System with a reservoir for perfusion management |
US9801527B2 (en) | 2004-04-19 | 2017-10-31 | Gearbox, Llc | Lumen-traveling biological interface device |
US8000784B2 (en) | 2004-04-19 | 2011-08-16 | The Invention Science Fund I, Llc | Lumen-traveling device |
US8361013B2 (en) | 2004-04-19 | 2013-01-29 | The Invention Science Fund I, Llc | Telescoping perfusion management system |
US8353896B2 (en) | 2004-04-19 | 2013-01-15 | The Invention Science Fund I, Llc | Controllable release nasal system |
US20060246109A1 (en) * | 2005-04-29 | 2006-11-02 | Hossainy Syed F | Concentration gradient profiles for control of agent release rates from polymer matrices |
US8293890B2 (en) * | 2004-04-30 | 2012-10-23 | Advanced Cardiovascular Systems, Inc. | Hyaluronic acid based copolymers |
MXPA06013029A (en) * | 2004-05-10 | 2007-02-12 | Novacea Inc | Prevention of arterial restenosis with active vitamin d compounds. |
US20050255230A1 (en) * | 2004-05-17 | 2005-11-17 | Clerc Claude O | Method of manufacturing a covered stent |
US8317859B2 (en) | 2004-06-28 | 2012-11-27 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US20050288766A1 (en) * | 2004-06-28 | 2005-12-29 | Xtent, Inc. | Devices and methods for controlling expandable prostheses during deployment |
US20050287184A1 (en) * | 2004-06-29 | 2005-12-29 | Hossainy Syed F A | Drug-delivery stent formulations for restenosis and vulnerable plaque |
US8709469B2 (en) | 2004-06-30 | 2014-04-29 | Abbott Cardiovascular Systems Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
US20060029720A1 (en) * | 2004-08-03 | 2006-02-09 | Anastasia Panos | Methods and apparatus for injection coating a medical device |
US8980300B2 (en) | 2004-08-05 | 2015-03-17 | Advanced Cardiovascular Systems, Inc. | Plasticizers for coating compositions |
US7901451B2 (en) * | 2004-09-24 | 2011-03-08 | Biosensors International Group, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
US20060069424A1 (en) * | 2004-09-27 | 2006-03-30 | Xtent, Inc. | Self-constrained segmented stents and methods for their deployment |
US20060085065A1 (en) * | 2004-10-15 | 2006-04-20 | Krause Arthur A | Stent with auxiliary treatment structure |
US20060095122A1 (en) * | 2004-10-29 | 2006-05-04 | Advanced Cardiovascular Systems, Inc. | Implantable devices comprising biologically absorbable star polymers and methods for fabricating the same |
US8388677B2 (en) * | 2004-10-29 | 2013-03-05 | Boston Scientific Scimed, Inc. | Anti-thrombogenic and anti-restenotic vascular medical devices |
US7481835B1 (en) * | 2004-10-29 | 2009-01-27 | Advanced Cardiovascular Systems, Inc. | Encapsulated covered stent |
US20060127443A1 (en) * | 2004-12-09 | 2006-06-15 | Helmus Michael N | Medical devices having vapor deposited nanoporous coatings for controlled therapeutic agent delivery |
US7632307B2 (en) | 2004-12-16 | 2009-12-15 | Advanced Cardiovascular Systems, Inc. | Abluminal, multilayer coating constructs for drug-delivery stents |
US8057543B2 (en) * | 2005-01-28 | 2011-11-15 | Greatbatch Ltd. | Stent coating for eluting medication |
US7749553B2 (en) * | 2005-01-31 | 2010-07-06 | Boston Scientific Scimed, Inc. | Method and system for coating a medical device using optical drop volume verification |
ES2564194T3 (en) | 2005-02-09 | 2016-03-18 | Santen Pharmaceutical Co., Ltd. | Liquid formulations for the treatment of diseases or ailments |
US7700659B2 (en) * | 2005-03-24 | 2010-04-20 | Advanced Cardiovascular Systems, Inc. | Implantable devices formed of non-fouling methacrylate or acrylate polymers |
US9381279B2 (en) | 2005-03-24 | 2016-07-05 | Abbott Cardiovascular Systems Inc. | Implantable devices formed on non-fouling methacrylate or acrylate polymers |
CA2603332C (en) * | 2005-03-31 | 2013-09-10 | Conor Medsystems, Inc. | System and method for loading a beneficial agent into a medical device |
AU2006231506B2 (en) | 2005-04-04 | 2012-08-30 | Intersect Ent, Inc. | Device and methods for treating paranasal sinus conditions |
US7402168B2 (en) * | 2005-04-11 | 2008-07-22 | Xtent, Inc. | Custom-length stent delivery system with independently operable expansion elements |
US8778375B2 (en) * | 2005-04-29 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Amorphous poly(D,L-lactide) coating |
US20060257355A1 (en) * | 2005-05-10 | 2006-11-16 | Abiomed, Inc. | Impregnated polymer compositions and devices using them |
CA2609687C (en) | 2005-05-24 | 2014-04-22 | Inspire M.D Ltd. | Stent apparatuses for treatment via body lumens and methods of use |
US8043323B2 (en) | 2006-10-18 | 2011-10-25 | Inspiremd Ltd. | In vivo filter assembly |
US8961586B2 (en) | 2005-05-24 | 2015-02-24 | Inspiremd Ltd. | Bifurcated stent assemblies |
US20060282149A1 (en) * | 2005-06-08 | 2006-12-14 | Xtent, Inc., A Delaware Corporation | Apparatus and methods for deployment of multiple custom-length prostheses (II) |
ES2691646T3 (en) | 2005-07-15 | 2018-11-28 | Micell Technologies, Inc. | Polymer coatings containing controlled morphology drug powder |
US20090062909A1 (en) * | 2005-07-15 | 2009-03-05 | Micell Technologies, Inc. | Stent with polymer coating containing amorphous rapamycin |
AU2011256902B2 (en) * | 2005-07-15 | 2015-03-12 | Micell Technologies, Inc. | Polymer coatings containing drug powder of controlled morphology |
US20070020312A1 (en) * | 2005-07-20 | 2007-01-25 | Desnoyer Jessica R | Method of fabricating a bioactive agent-releasing implantable medical device |
WO2007040485A1 (en) * | 2005-09-22 | 2007-04-12 | Novovascular, Inc. | Stent covered by a layer having a layer opening |
US20070104753A1 (en) * | 2005-11-04 | 2007-05-10 | Aiden Flanagan | Medical device with a coating comprising an active form and an inactive form of therapeutic agent(s) |
US20070196423A1 (en) * | 2005-11-21 | 2007-08-23 | Med Institute, Inc. | Implantable medical device coatings with biodegradable elastomer and releasable therapeutic agent |
WO2007066339A1 (en) * | 2005-12-07 | 2007-06-14 | Ramot At Tel Aviv University Ltd. | Drug-delivering composite structures |
US20070142903A1 (en) * | 2005-12-15 | 2007-06-21 | Dave Vipul B | Laser cut intraluminal medical devices |
US7842312B2 (en) * | 2005-12-29 | 2010-11-30 | Cordis Corporation | Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same |
WO2007081530A2 (en) * | 2006-01-03 | 2007-07-19 | Med Institute, Inc. | Endoluminal medical device for local delivery of cathepsin inhibitors |
WO2007089780A2 (en) * | 2006-01-30 | 2007-08-09 | Licentia, Ltd. | Bmx/etk tyrosine kinase gene therapy materials and methods |
US20070179587A1 (en) * | 2006-01-30 | 2007-08-02 | Xtent, Inc. | Apparatus and methods for deployment of custom-length prostheses |
JP2009525110A (en) | 2006-01-31 | 2009-07-09 | マルチ ジーン バスキュラー システムズ, インコーポレイテッド | Drug-eluting endovascular prostheses and methods of use |
US20070178137A1 (en) * | 2006-02-01 | 2007-08-02 | Toby Freyman | Local control of inflammation |
BRPI0707612B8 (en) | 2006-02-09 | 2021-05-25 | Macusight Inc | sealed vessel and liquid formulations contained therein |
AU2007217355B2 (en) | 2006-02-27 | 2012-06-21 | Vertex Pharmaceuticals Incorporated | Co-crystals comprising VX-950 and pharmaceutical compositions comprising the same |
US7622477B2 (en) * | 2006-02-28 | 2009-11-24 | Cordis Corporation | Isomers and 42-epimers of rapamycin alkyl ether analogs, methods of making and using the same |
US8652198B2 (en) | 2006-03-20 | 2014-02-18 | J.W. Medical Systems Ltd. | Apparatus and methods for deployment of linked prosthetic segments |
US8222271B2 (en) | 2006-03-23 | 2012-07-17 | Santen Pharmaceutical Co., Ltd. | Formulations and methods for vascular permeability-related diseases or conditions |
US20070224235A1 (en) | 2006-03-24 | 2007-09-27 | Barron Tenney | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
US8187620B2 (en) | 2006-03-27 | 2012-05-29 | Boston Scientific Scimed, Inc. | Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
JP5102200B2 (en) * | 2006-03-30 | 2012-12-19 | テルモ株式会社 | In vivo indwelling |
WO2007116646A1 (en) * | 2006-04-04 | 2007-10-18 | Terumo Kabushiki Kaisha | In vivo indwelling object |
US20080058788A1 (en) | 2006-04-12 | 2008-03-06 | Searete Llc., A Limited Liability Corporation Of The State Of Delaware | Autofluorescent imaging and target ablation |
US9198563B2 (en) | 2006-04-12 | 2015-12-01 | The Invention Science Fund I, Llc | Temporal control of a lumen traveling device in a body tube tree |
US7879086B2 (en) * | 2006-04-20 | 2011-02-01 | Boston Scientific Scimed, Inc. | Medical device having a coating comprising an adhesion promoter |
EP2944382A1 (en) | 2006-04-26 | 2015-11-18 | Micell Technologies, Inc. | Coatings containing multiple drugs |
US20070254003A1 (en) * | 2006-05-01 | 2007-11-01 | Pu Zhou | Non-sticky coatings with therapeutic agents for medical devices |
US20070276486A1 (en) * | 2006-05-25 | 2007-11-29 | E. Benson Hood Laboratories | Coated tracheostomy tube and stoma stent or cannula |
WO2007140320A2 (en) | 2006-05-26 | 2007-12-06 | Nanyang Technological University | Implantable article, method of forming same and method for reducing thrombogenicity |
US9561351B2 (en) * | 2006-05-31 | 2017-02-07 | Advanced Cardiovascular Systems, Inc. | Drug delivery spiral coil construct |
US20070281117A1 (en) * | 2006-06-02 | 2007-12-06 | Xtent, Inc. | Use of plasma in formation of biodegradable stent coating |
US20080095918A1 (en) * | 2006-06-14 | 2008-04-24 | Kleiner Lothar W | Coating construct with enhanced interfacial compatibility |
US8246973B2 (en) | 2006-06-21 | 2012-08-21 | Advanced Cardiovascular Systems, Inc. | Freeze-thaw method for modifying stent coating |
US8679573B2 (en) * | 2006-06-28 | 2014-03-25 | Advanced Cardiovascular Systems, Inc. | Stent coating method and apparatus |
US8815275B2 (en) | 2006-06-28 | 2014-08-26 | Boston Scientific Scimed, Inc. | Coatings for medical devices comprising a therapeutic agent and a metallic material |
US8388573B1 (en) | 2006-06-28 | 2013-03-05 | Abbott Cardiovascular Systems Inc. | Local delivery with a balloon covered by a cage |
EP2032091A2 (en) | 2006-06-29 | 2009-03-11 | Boston Scientific Limited | Medical devices with selective coating |
US8956640B2 (en) * | 2006-06-29 | 2015-02-17 | Advanced Cardiovascular Systems, Inc. | Block copolymers including a methoxyethyl methacrylate midblock |
US20080008736A1 (en) * | 2006-07-06 | 2008-01-10 | Thierry Glauser | Random copolymers of methacrylates and acrylates |
US20080091262A1 (en) * | 2006-10-17 | 2008-04-17 | Gale David C | Drug delivery after biodegradation of the stent scaffolding |
US8016879B2 (en) | 2006-08-01 | 2011-09-13 | Abbott Cardiovascular Systems Inc. | Drug delivery after biodegradation of the stent scaffolding |
CN100465209C (en) * | 2006-08-17 | 2009-03-04 | 同济大学 | Preparation method of degradable polymer material for stent in shape memory pipe cavity |
ATE508708T1 (en) | 2006-09-14 | 2011-05-15 | Boston Scient Ltd | MEDICAL DEVICES WITH A DRUG-RELEASING COATING |
US20080069858A1 (en) * | 2006-09-20 | 2008-03-20 | Boston Scientific Scimed, Inc. | Medical devices having biodegradable polymeric regions with overlying hard, thin layers |
WO2008042909A2 (en) * | 2006-10-02 | 2008-04-10 | Micell Technologies Inc. | Surgical sutures having increased strength |
WO2008047369A2 (en) | 2006-10-18 | 2008-04-24 | Inspiremd Ltd. | Knitted stent jackets |
EP1916006A1 (en) * | 2006-10-19 | 2008-04-30 | Albert Schömig | Implant coated with a wax or a resin |
EP1913960A1 (en) * | 2006-10-19 | 2008-04-23 | Albert Schömig | Coated implant |
US8067055B2 (en) * | 2006-10-20 | 2011-11-29 | Biosensors International Group, Ltd. | Drug-delivery endovascular stent and method of use |
US20080097591A1 (en) | 2006-10-20 | 2008-04-24 | Biosensors International Group | Drug-delivery endovascular stent and method of use |
CA2667228C (en) | 2006-10-23 | 2015-07-14 | Micell Technologies, Inc. | Holder for electrically charging a substrate during coating |
US20080103584A1 (en) * | 2006-10-25 | 2008-05-01 | Biosensors International Group | Temporal Intraluminal Stent, Methods of Making and Using |
US7981150B2 (en) | 2006-11-09 | 2011-07-19 | Boston Scientific Scimed, Inc. | Endoprosthesis with coatings |
US20080294236A1 (en) * | 2007-05-23 | 2008-11-27 | Boston Scientific Scimed, Inc. | Endoprosthesis with Select Ceramic and Polymer Coatings |
WO2008062414A2 (en) | 2006-11-22 | 2008-05-29 | Inspiremd Ltd. | Optimized stent jacket |
CA2673528A1 (en) * | 2006-12-20 | 2008-07-24 | Boston Scientific Limited | Stent with a coating for delivering a therapeutic agent |
US11426494B2 (en) | 2007-01-08 | 2022-08-30 | MT Acquisition Holdings LLC | Stents having biodegradable layers |
CN101711137B (en) | 2007-01-08 | 2014-10-22 | 米歇尔技术公司 | Stents having biodegradable layers |
US8221496B2 (en) * | 2007-02-01 | 2012-07-17 | Cordis Corporation | Antithrombotic and anti-restenotic drug eluting stent |
US20080199510A1 (en) | 2007-02-20 | 2008-08-21 | Xtent, Inc. | Thermo-mechanically controlled implants and methods of use |
ES2379905T3 (en) | 2007-02-27 | 2012-05-04 | Vertex Pharmceuticals Incorporated | Co-crystals and pharmaceutical compositions comprising them |
US8431149B2 (en) | 2007-03-01 | 2013-04-30 | Boston Scientific Scimed, Inc. | Coated medical devices for abluminal drug delivery |
US8070797B2 (en) | 2007-03-01 | 2011-12-06 | Boston Scientific Scimed, Inc. | Medical device with a porous surface for delivery of a therapeutic agent |
US8486132B2 (en) | 2007-03-22 | 2013-07-16 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US8067054B2 (en) | 2007-04-05 | 2011-11-29 | Boston Scientific Scimed, Inc. | Stents with ceramic drug reservoir layer and methods of making and using the same |
BRPI0810370A2 (en) * | 2007-04-17 | 2014-10-29 | Micell Technologies Inc | STENT COATED, AND METHOD FOR PREPARING A STENT |
US7976915B2 (en) | 2007-05-23 | 2011-07-12 | Boston Scientific Scimed, Inc. | Endoprosthesis with select ceramic morphology |
US8084077B2 (en) * | 2007-05-25 | 2011-12-27 | Abbott Laboratories | One-step phosphorylcholine-linked polymer coating and drug loading of stent |
CA2688314C (en) * | 2007-05-25 | 2013-12-03 | Micell Technologies, Inc. | Polymer films for medical device coating |
US20100070020A1 (en) | 2008-06-11 | 2010-03-18 | Nanovasc, Inc. | Implantable Medical Device |
US8002823B2 (en) | 2007-07-11 | 2011-08-23 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US7942926B2 (en) | 2007-07-11 | 2011-05-17 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US9284409B2 (en) | 2007-07-19 | 2016-03-15 | Boston Scientific Scimed, Inc. | Endoprosthesis having a non-fouling surface |
DE102007034364A1 (en) * | 2007-07-24 | 2009-01-29 | Biotronik Vi Patent Ag | Degradable metal stent with active ingredient-containing coating |
US7931683B2 (en) | 2007-07-27 | 2011-04-26 | Boston Scientific Scimed, Inc. | Articles having ceramic coated surfaces |
US8815273B2 (en) | 2007-07-27 | 2014-08-26 | Boston Scientific Scimed, Inc. | Drug eluting medical devices having porous layers |
WO2009018340A2 (en) | 2007-07-31 | 2009-02-05 | Boston Scientific Scimed, Inc. | Medical device coating by laser cladding |
EP2185103B1 (en) | 2007-08-03 | 2014-02-12 | Boston Scientific Scimed, Inc. | Coating for medical device having increased surface area |
US20090041845A1 (en) * | 2007-08-08 | 2009-02-12 | Lothar Walter Kleiner | Implantable medical devices having thin absorbable coatings |
US20090043380A1 (en) * | 2007-08-09 | 2009-02-12 | Specialized Vascular Technologies, Inc. | Coatings for promoting endothelization of medical devices |
US20090043330A1 (en) * | 2007-08-09 | 2009-02-12 | Specialized Vascular Technologies, Inc. | Embolic protection devices and methods |
NZ583699A (en) | 2007-08-30 | 2012-04-27 | Vertex Pharma | Co-crystals of vx-950 (telaprevir) other components and pharmaceutical compositions comprising the same |
WO2009033026A1 (en) * | 2007-09-06 | 2009-03-12 | Boston Scientific Scimed, Inc. | Methods and devices for local therapeutic agent delivery to heart valves |
US8100855B2 (en) | 2007-09-17 | 2012-01-24 | Abbott Cardiovascular Systems, Inc. | Methods and devices for eluting agents to a vessel |
KR100930167B1 (en) * | 2007-09-19 | 2009-12-07 | 삼성전기주식회사 | Ultra wide angle optical system |
US20090076584A1 (en) * | 2007-09-19 | 2009-03-19 | Xtent, Inc. | Apparatus and methods for deployment of multiple custom-length prostheses |
US9814553B1 (en) | 2007-10-10 | 2017-11-14 | Abbott Cardiovascular Systems Inc. | Bioabsorbable semi-crystalline polymer for controlling release of drug from a coating |
US8661630B2 (en) * | 2008-05-21 | 2014-03-04 | Abbott Cardiovascular Systems Inc. | Coating comprising an amorphous primer layer and a semi-crystalline reservoir layer |
US8142490B2 (en) * | 2007-10-24 | 2012-03-27 | Cordis Corporation | Stent segments axially connected by thin film |
US8642062B2 (en) | 2007-10-31 | 2014-02-04 | Abbott Cardiovascular Systems Inc. | Implantable device having a slow dissolving polymer |
US20090112239A1 (en) * | 2007-10-31 | 2009-04-30 | Specialized Vascular Technologies, Inc. | Sticky dilatation balloon and methods of using |
US8216632B2 (en) | 2007-11-02 | 2012-07-10 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US20090118821A1 (en) * | 2007-11-02 | 2009-05-07 | Boston Scientific Scimed, Inc. | Endoprosthesis with porous reservoir and non-polymer diffusion layer |
US20090118812A1 (en) * | 2007-11-02 | 2009-05-07 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US7938855B2 (en) | 2007-11-02 | 2011-05-10 | Boston Scientific Scimed, Inc. | Deformable underlayer for stent |
US8029554B2 (en) | 2007-11-02 | 2011-10-04 | Boston Scientific Scimed, Inc. | Stent with embedded material |
JP5693228B2 (en) | 2007-11-14 | 2015-04-01 | バイオセンサーズ インターナショナル グループ、リミテッド | Automatic coating apparatus and method |
EP2229379A2 (en) | 2007-12-07 | 2010-09-22 | Vertex Pharmaceuticals Incorporated | Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1h-benzo[d]imidazol-2-yl)urea |
CN101945621B (en) | 2007-12-18 | 2014-06-18 | 因特尔赛克特耳鼻喉公司 | Self-expanding devices and methods therefor |
US20090186068A1 (en) * | 2008-01-18 | 2009-07-23 | Chameleon Scientific Corporation | Atomic plasma deposited coatings for drug release |
US20090196900A1 (en) * | 2008-02-01 | 2009-08-06 | Medtronic Vascular, Inc. | Use of Phosphodiesterase Inhibitor as a Component of Implantable Medical Devices |
US9603980B2 (en) * | 2008-02-26 | 2017-03-28 | CARDINAL HEALTH SWITZERLAND 515 GmbH | Layer-by-layer stereocomplexed polymers as drug depot carriers or coatings in medical devices |
US9101503B2 (en) | 2008-03-06 | 2015-08-11 | J.W. Medical Systems Ltd. | Apparatus having variable strut length and methods of use |
US8377116B2 (en) * | 2008-03-20 | 2013-02-19 | Abbott Cardiovascular Systems Inc. | Implantable medical device coatings with improved mechanical stability |
CN101264351B (en) * | 2008-04-07 | 2011-08-24 | 易生科技(北京)有限公司 | Composite coating cardiovascular medicaments elution stent and preparation thereof |
US10456259B2 (en) | 2008-04-16 | 2019-10-29 | Heart Repair Technologies, Inc. | Transvalvular intraannular band for mitral valve repair |
US20100121435A1 (en) | 2008-04-16 | 2010-05-13 | Cardiovascular Technologies, Llc | Percutaneous transvalvular intrannular band for mitral valve repair |
US20100121437A1 (en) | 2008-04-16 | 2010-05-13 | Cardiovascular Technologies, Llc | Transvalvular intraannular band and chordae cutting for ischemic and dilated cardiomyopathy |
US11083579B2 (en) | 2008-04-16 | 2021-08-10 | Heart Repair Technologies, Inc. | Transvalvular intraanular band and chordae cutting for ischemic and dilated cardiomyopathy |
US11013599B2 (en) | 2008-04-16 | 2021-05-25 | Heart Repair Technologies, Inc. | Percutaneous transvalvular intraannular band for mitral valve repair |
EP2271294B1 (en) | 2008-04-17 | 2018-03-28 | Micell Technologies, Inc. | Stents having bioabsorbable layers |
US8916188B2 (en) * | 2008-04-18 | 2014-12-23 | Abbott Cardiovascular Systems Inc. | Block copolymer comprising at least one polyester block and a poly (ethylene glycol) block |
US20090285873A1 (en) * | 2008-04-18 | 2009-11-19 | Abbott Cardiovascular Systems Inc. | Implantable medical devices and coatings therefor comprising block copolymers of poly(ethylene glycol) and a poly(lactide-glycolide) |
EP2271380B1 (en) | 2008-04-22 | 2013-03-20 | Boston Scientific Scimed, Inc. | Medical devices having a coating of inorganic material |
US8932346B2 (en) | 2008-04-24 | 2015-01-13 | Boston Scientific Scimed, Inc. | Medical devices having inorganic particle layers |
EP3159033B1 (en) | 2008-05-01 | 2019-02-27 | Bayer Intellectual Property GmbH | Catheter balloon drug adherence techniques and methods |
US8986728B2 (en) | 2008-05-30 | 2015-03-24 | Abbott Cardiovascular Systems Inc. | Soluble implantable device comprising polyelectrolyte with hydrophobic counterions |
US9943614B2 (en) | 2008-06-17 | 2018-04-17 | Brigham Young University | Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods |
EP2303350A2 (en) | 2008-06-18 | 2011-04-06 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8206636B2 (en) | 2008-06-20 | 2012-06-26 | Amaranth Medical Pte. | Stent fabrication via tubular casting processes |
US10898620B2 (en) | 2008-06-20 | 2021-01-26 | Razmodics Llc | Composite stent having multi-axial flexibility and method of manufacture thereof |
US8206635B2 (en) | 2008-06-20 | 2012-06-26 | Amaranth Medical Pte. | Stent fabrication via tubular casting processes |
US8562669B2 (en) * | 2008-06-26 | 2013-10-22 | Abbott Cardiovascular Systems Inc. | Methods of application of coatings composed of hydrophobic, high glass transition polymers with tunable drug release rates |
US9510856B2 (en) | 2008-07-17 | 2016-12-06 | Micell Technologies, Inc. | Drug delivery medical device |
AU2009270849B2 (en) | 2008-07-17 | 2013-11-21 | Micell Technologies, Inc. | Drug delivery medical device |
US8763222B2 (en) | 2008-08-01 | 2014-07-01 | Intersect Ent, Inc. | Methods and devices for crimping self-expanding devices |
US8642063B2 (en) | 2008-08-22 | 2014-02-04 | Cook Medical Technologies Llc | Implantable medical device coatings with biodegradable elastomer and releasable taxane agent |
US20100055145A1 (en) * | 2008-08-29 | 2010-03-04 | Biosensors International Group | Stent coatings for reducing late stent thrombosis |
US8769796B2 (en) | 2008-09-25 | 2014-07-08 | Advanced Bifurcation Systems, Inc. | Selective stent crimping |
US8795347B2 (en) | 2008-09-25 | 2014-08-05 | Advanced Bifurcation Systems, Inc. | Methods and systems for treating a bifurcation with provisional side branch stenting |
US8821562B2 (en) | 2008-09-25 | 2014-09-02 | Advanced Bifurcation Systems, Inc. | Partially crimped stent |
US11298252B2 (en) | 2008-09-25 | 2022-04-12 | Advanced Bifurcation Systems Inc. | Stent alignment during treatment of a bifurcation |
CN102215780B (en) | 2008-09-25 | 2015-10-14 | 高级分支系统股份有限公司 | Part crimped stent |
US8500687B2 (en) | 2008-09-25 | 2013-08-06 | Abbott Cardiovascular Systems Inc. | Stent delivery system having a fibrous matrix covering with improved stent retention |
GB0819296D0 (en) * | 2008-10-21 | 2008-11-26 | Smith & Nephew | Coating II |
US20100119578A1 (en) * | 2008-11-07 | 2010-05-13 | Specialized Vascular Technologies, Inc. | Extracellular matrix modulating coatings for medical devices |
US8231980B2 (en) | 2008-12-03 | 2012-07-31 | Boston Scientific Scimed, Inc. | Medical implants including iridium oxide |
US8834913B2 (en) | 2008-12-26 | 2014-09-16 | Battelle Memorial Institute | Medical implants and methods of making medical implants |
CA2752544A1 (en) | 2009-02-13 | 2010-08-19 | Vertex Pharmaceuticals Incorporated | Solid forms of 2-(2, 4-difluorophenyl)-6-(1-(2,6-difluorophenyl)ureido)nicotinamide |
US8071156B2 (en) | 2009-03-04 | 2011-12-06 | Boston Scientific Scimed, Inc. | Endoprostheses |
WO2010111232A2 (en) * | 2009-03-23 | 2010-09-30 | Micell Technologies, Inc. | Drug delivery medical device |
WO2010120552A2 (en) * | 2009-04-01 | 2010-10-21 | Micell Technologies, Inc. | Coated stents |
US8735506B2 (en) * | 2009-04-03 | 2014-05-27 | Ashland Licensing And Intellectual Property Llc | Ultraviolet radiation curable pressure sensitive acrylic adhesive |
WO2010121187A2 (en) | 2009-04-17 | 2010-10-21 | Micell Techologies, Inc. | Stents having controlled elution |
US8287937B2 (en) | 2009-04-24 | 2012-10-16 | Boston Scientific Scimed, Inc. | Endoprosthese |
US10357640B2 (en) | 2009-05-15 | 2019-07-23 | Intersect Ent, Inc. | Expandable devices and methods for treating a nasal or sinus condition |
AU2010249558A1 (en) * | 2009-05-20 | 2011-12-08 | Arsenal Medical, Inc. | Medical implant |
US9265633B2 (en) | 2009-05-20 | 2016-02-23 | 480 Biomedical, Inc. | Drug-eluting medical implants |
EP2444034B1 (en) | 2009-09-30 | 2017-05-31 | Terumo Kabushiki Kaisha | Stent |
WO2011044533A2 (en) | 2009-10-09 | 2011-04-14 | Specialized Vascular Technologies, Inc. | Coating system and method for drug elution management |
EP2338534A2 (en) * | 2009-12-21 | 2011-06-29 | Biotronik VI Patent AG | Medical implant, coating method and implantation method |
US11369498B2 (en) | 2010-02-02 | 2022-06-28 | MT Acquisition Holdings LLC | Stent and stent delivery system with improved deliverability |
CN109363807B (en) | 2010-03-24 | 2021-04-02 | 高级分支系统股份有限公司 | System and method for treating a bifurcation |
CA2794078A1 (en) | 2010-03-24 | 2011-09-29 | Advanced Bifurcation Systems, Inc. | Stent alignment during treatment of a bifurcation |
US8795762B2 (en) | 2010-03-26 | 2014-08-05 | Battelle Memorial Institute | System and method for enhanced electrostatic deposition and surface coatings |
US8685433B2 (en) | 2010-03-31 | 2014-04-01 | Abbott Cardiovascular Systems Inc. | Absorbable coating for implantable device |
EP2555811B1 (en) | 2010-04-06 | 2017-09-27 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US10232092B2 (en) | 2010-04-22 | 2019-03-19 | Micell Technologies, Inc. | Stents and other devices having extracellular matrix coating |
DE102010018541A1 (en) * | 2010-04-28 | 2011-11-03 | Acandis Gmbh & Co. Kg | Method of manufacturing a medical device |
US20130032967A1 (en) * | 2010-05-07 | 2013-02-07 | Abbott Cardiovascular Systems Inc. | Cold ethylene oxide sterilization of a biodegradable polymeric stent |
CA2805631C (en) | 2010-07-16 | 2018-07-31 | Micell Technologies, Inc. | Drug delivery medical device |
CN102464669B (en) * | 2010-11-17 | 2014-04-16 | 浙江海正药业股份有限公司 | Amorphous everolimus and preparation method thereof |
EP2640730B1 (en) * | 2010-11-19 | 2019-08-07 | Biocon Limited | Processes for preparation of everolimus and intermediates thereof |
AU2012205415B2 (en) * | 2011-01-14 | 2017-02-02 | Spero Therapeutics, Inc. | Pyrimidine gyrase and topoisomerase IV inhibitors |
RU2625305C2 (en) | 2011-01-14 | 2017-07-13 | Сперо Тринем, Инк. | Solid forms of gyrase inhibitor (r)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl) pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1h-benzimidazol-2-yl] urea |
WO2012103959A1 (en) | 2011-02-04 | 2012-08-09 | Synthon Bv | Process for making everolimus |
WO2012109365A1 (en) | 2011-02-08 | 2012-08-16 | Advanced Bifurcation Systems, Inc. | System and methods for treating a bifurcation with a fully crimped stent |
WO2012109382A2 (en) | 2011-02-08 | 2012-08-16 | Advanced Bifurcation Systems, Inc. | Multi-stent and multi-balloon apparatus for treating bifurcations and methods of use |
US9187953B2 (en) | 2011-03-23 | 2015-11-17 | Rytec Corporation | Side column configuration for overhead roll-up door assemblies |
WO2012142319A1 (en) * | 2011-04-13 | 2012-10-18 | Micell Technologies, Inc. | Stents having controlled elution |
WO2012166819A1 (en) | 2011-05-31 | 2012-12-06 | Micell Technologies, Inc. | System and process for formation of a time-released, drug-eluting transferable coating |
TWI554515B (en) | 2011-06-20 | 2016-10-21 | 維泰克斯製藥公司 | Phosphate esters of gyrase and topoisomerase inhibitors |
CN102389585B (en) * | 2011-07-07 | 2014-04-23 | 中山大学 | Method for loading active molecules on surface of biomedical material |
CA2841360A1 (en) | 2011-07-15 | 2013-01-24 | Micell Technologies, Inc. | Drug delivery medical device |
WO2013013223A1 (en) | 2011-07-20 | 2013-01-24 | Brigham Young University | Hydrogel materials incorporating eluting ceragenin compound |
US8945217B2 (en) * | 2011-08-25 | 2015-02-03 | Brigham Young University | Medical devices incorporating ceragenin-containing composites |
US9603859B2 (en) | 2011-09-13 | 2017-03-28 | Brigham Young University | Methods and products for increasing the rate of healing of tissue wounds |
JP6038155B2 (en) | 2011-09-13 | 2016-12-07 | ブリガム・ヤング・ユニバーシティBrigham Young University | Products for healing tissue wounds |
JP6038154B2 (en) | 2011-09-13 | 2016-12-07 | ブリガム・ヤング・ユニバーシティBrigham Young University | Composition for the treatment of bone disease and fractured bone |
US9694019B2 (en) | 2011-09-13 | 2017-07-04 | Brigham Young University | Compositions and methods for treating bone diseases and broken bones |
US10188772B2 (en) | 2011-10-18 | 2019-01-29 | Micell Technologies, Inc. | Drug delivery medical device |
WO2013109236A2 (en) | 2011-12-21 | 2013-07-25 | Colgate-Palmolive Company | Oral care compositions |
US9220759B2 (en) | 2012-02-23 | 2015-12-29 | Abbott Cardiovascular Systems Inc. | Treatment of diabetic patients with a drug eluting stent and adjunctive therapy |
US9533063B1 (en) | 2012-03-01 | 2017-01-03 | Brigham Young University | Aerosols incorporating ceragenin compounds and methods of use thereof |
US9220584B2 (en) | 2012-03-30 | 2015-12-29 | Abbott Cardiovascular Systems Inc. | Treatment of diabetic patients with a stent and locally administered adjunctive therapy |
US10039285B2 (en) | 2012-05-02 | 2018-08-07 | Brigham Young University | Ceragenin particulate materials and methods for making same |
CN102786534A (en) * | 2012-05-25 | 2012-11-21 | 上海现代制药股份有限公司 | Preparation method of everolimus |
EP2859001B1 (en) * | 2012-06-08 | 2016-04-13 | Biotronik AG | Rapamycin 40-o-cyclic hydrocarbon esters, compositions and methods |
WO2014010759A1 (en) * | 2012-07-10 | 2014-01-16 | 주식회사 엠아이텍 | Cylindrical structure having lumen inserted into human body |
US9018216B2 (en) | 2012-07-18 | 2015-04-28 | Vertex Pharmaceuticals Incorporated | Solid forms of (R)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1H-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof |
CN102784418B (en) * | 2012-08-10 | 2014-04-16 | 中国医学科学院生物医学工程研究所 | Procedurally-released biological drug nanoporous intravascular stent, preparation method and application thereof |
EP2882381B1 (en) * | 2012-08-10 | 2018-12-26 | Lombard Medical Limited | Stent delivery system |
ES2654189T3 (en) * | 2012-09-12 | 2018-02-12 | Boston Scientific Scimed, Inc. | Anti-migration stent adhesive coating |
BR112015008804A2 (en) | 2012-10-17 | 2017-07-04 | Univ Brigham Young | mastitis treatment and prevention |
EP2737894A1 (en) | 2012-12-03 | 2014-06-04 | Debiotech S.A. | Smart coating for implantable devices |
CA2897150C (en) | 2013-01-07 | 2021-07-13 | Brigham Young University | Methods for reducing cellular proliferation and treating certain diseases |
US11039943B2 (en) | 2013-03-12 | 2021-06-22 | Micell Technologies, Inc. | Bioabsorbable biomedical implants |
JP6399663B2 (en) | 2013-03-14 | 2018-10-03 | インターセクト エント, インコーポレイテッド | System, device and method for treating sinus conditions |
AU2014234992B2 (en) | 2013-03-15 | 2018-01-18 | Brigham Young University | Methods for treating inflammation, autoimmune disorders and pain |
US11524015B2 (en) | 2013-03-15 | 2022-12-13 | Brigham Young University | Methods for treating inflammation, autoimmune disorders and pain |
US10568893B2 (en) | 2013-03-15 | 2020-02-25 | Brigham Young University | Methods for treating inflammation, autoimmune disorders and pain |
US9387215B2 (en) | 2013-04-22 | 2016-07-12 | Brigham Young University | Animal feed including cationic cholesterol additive and related methods |
JP2016519965A (en) | 2013-05-15 | 2016-07-11 | マイセル・テクノロジーズ,インコーポレイテッド | Bioabsorbable biomedical implant |
WO2015020527A1 (en) | 2013-08-09 | 2015-02-12 | Maastricht University | Biodegradable radiopaque stents and other implants |
US11690855B2 (en) | 2013-10-17 | 2023-07-04 | Brigham Young University | Methods for treating lung infections and inflammation |
SI3057953T1 (en) | 2013-10-17 | 2018-12-31 | Vertex Pharmaceuticals Incorporated | Co-crystals of (s)-n-methyl-8-(1-((2'-methyl-(4,5'-bipyrimidin)-6-yl)amino)propan-2-yl)quinoline-4-carboxamide and deuterated derivatives thereof as dna-pk inhibitors |
US9459193B2 (en) * | 2013-12-18 | 2016-10-04 | Abbott Cardiovascular Systems Inc. | Stent holder having a reduced profile |
US20150203527A1 (en) | 2014-01-23 | 2015-07-23 | Brigham Young University | Cationic steroidal antimicrobials |
CA2844321C (en) | 2014-02-27 | 2021-03-16 | Brigham Young University | Cationic steroidal antimicrobial compounds |
US9867836B2 (en) | 2014-03-13 | 2018-01-16 | Brigham Young University | Lavage and/or infusion using CSA compounds for increasing fertility in a mammal |
US10220045B2 (en) | 2014-03-13 | 2019-03-05 | Brigham Young University | Compositions and methods for forming stabilized compositions with reduced CSA agglomeration |
US9931350B2 (en) | 2014-03-14 | 2018-04-03 | Brigham Young University | Anti-infective and osteogenic compositions and methods of use |
WO2015160998A2 (en) | 2014-04-17 | 2015-10-22 | Abbott Cardiovascular Systems Inc. | Coatings for braided medical devices and methods of forming same |
EP3136807A4 (en) | 2014-04-21 | 2017-12-20 | Kabushiki Kaisha Toshiba | Integrated circuit for radio communication |
EP3136804B1 (en) | 2014-04-21 | 2021-09-01 | Kabushiki Kaisha Toshiba | Base stations and wireless communication methods |
US9686966B2 (en) | 2014-04-30 | 2017-06-27 | Brigham Young University | Methods and apparatus for cleaning or disinfecting a water delivery system |
US10441595B2 (en) | 2014-06-26 | 2019-10-15 | Brigham Young University | Methods for treating fungal infections |
US10238665B2 (en) | 2014-06-26 | 2019-03-26 | Brigham Young University | Methods for treating fungal infections |
US9938297B2 (en) | 2014-08-04 | 2018-04-10 | Cipia Limited | Process for the synthesis of everolimus and intermediates thereof |
DE102014111117B4 (en) * | 2014-08-05 | 2017-11-16 | Acandis Gmbh & Co. Kg | Medical device for the treatment of neurovascular diseases, system and set with such a device and manufacturing method |
US10227376B2 (en) | 2014-08-22 | 2019-03-12 | Brigham Young University | Radiolabeled cationic steroid antimicrobials and diagnostic methods |
US10155788B2 (en) | 2014-10-07 | 2018-12-18 | Brigham Young University | Cationic steroidal antimicrobial prodrug compositions and uses thereof |
CN104478898A (en) * | 2014-11-18 | 2015-04-01 | 连云港恒运医药科技有限公司 | Preparation method of everolimus and intermediate of everolimus |
JPWO2016114216A1 (en) * | 2015-01-13 | 2017-10-19 | テルモ株式会社 | Biodegradable stent |
CN104592254B (en) * | 2015-02-08 | 2016-07-13 | 福建省微生物研究所 | The synthetic method of everolimus |
US9527883B2 (en) | 2015-04-22 | 2016-12-27 | Brigham Young University | Methods for the synthesis of ceragenins |
US10370403B2 (en) | 2015-04-22 | 2019-08-06 | Brigham Young University | Methods for the synthesis of ceragenins |
US9434759B1 (en) | 2015-05-18 | 2016-09-06 | Brigham Young University | Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds |
EP4268864A3 (en) * | 2015-09-25 | 2024-01-24 | Spirox, Inc. | Nasal implants |
CN105566348A (en) * | 2015-12-31 | 2016-05-11 | 哈药集团技术中心 | Preparation method of everolimus |
US10226550B2 (en) | 2016-03-11 | 2019-03-12 | Brigham Young University | Cationic steroidal antimicrobial compositions for the treatment of dermal tissue |
WO2018112203A1 (en) * | 2016-12-14 | 2018-06-21 | eLum Technologies, Inc. | Electrospun stents, flow diverters, and occlusion devices and methods of making the same |
US20190358369A1 (en) * | 2016-12-22 | 2019-11-28 | Biotronik Ag | Drug releasing coatings for medical devices and methods of making same |
WO2018119304A1 (en) | 2016-12-22 | 2018-06-28 | Heart Repair Technologies, Inc. | Percutaneous delivery systems for anchoring an implant in a cardiac valve annulus |
US10959433B2 (en) | 2017-03-21 | 2021-03-30 | Brigham Young University | Use of cationic steroidal antimicrobials for sporicidal activity |
EP3740167A4 (en) * | 2018-01-16 | 2021-11-03 | Sintra Medical Llc | Stents with increased flexibility |
CN108720971A (en) * | 2018-01-28 | 2018-11-02 | 杭州市第人民医院 | A kind of controllable antibacterial trachea bracket |
US11224512B2 (en) * | 2018-03-21 | 2022-01-18 | Edwards Lifesciences Corporation | Coronary artery check valve |
BR112020019801A8 (en) | 2018-03-29 | 2023-02-07 | Sahajanand Medical Tech Limited | STENT |
RU2686747C1 (en) * | 2018-11-08 | 2019-04-30 | Федеральное государственное бюджетное учреждение науки Институт металлургии и материаловедения им. А.А. Байкова Российской академии наук (ИМЕТ РАН) | METHOD OF PRODUCING BIODEGRADABLE POLYMER COATING BASED ON POLYLACTIDE ON TiNbTaZr WIRE |
CN113226389B (en) * | 2018-11-14 | 2022-11-08 | 乐通公司 | Medical device with drug eluting coating on modified device surface |
CN114105836B (en) * | 2020-08-27 | 2024-03-15 | 鲁南制药集团股份有限公司 | Derivative compound of ethylene glycol |
WO2024068153A1 (en) * | 2022-09-30 | 2024-04-04 | Biotronik Ag | Macrocyclic triene immunosuppressive compounds for perivascular medical treatment of vascular access fistulas, grafts and other vascular conditions |
CN116869715B (en) * | 2023-07-10 | 2024-02-09 | 上海心玮医疗科技股份有限公司 | Anticoagulation medicine elution support |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6273913B1 (en) * | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
Family Cites Families (108)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US517698A (en) | 1894-04-03 | Druggist s weighing-scale | ||
ZA737247B (en) | 1972-09-29 | 1975-04-30 | Ayerst Mckenna & Harrison | Rapamycin and process of preparation |
US4885171A (en) | 1978-11-03 | 1989-12-05 | American Home Products Corporation | Use of rapamycin in treatment of certain tumors |
US4316885A (en) | 1980-08-25 | 1982-02-23 | Ayerst, Mckenna And Harrison, Inc. | Acyl derivatives of rapamycin |
US4650803A (en) | 1985-12-06 | 1987-03-17 | University Of Kansas | Prodrugs of rapamycin |
US5527337A (en) | 1987-06-25 | 1996-06-18 | Duke University | Bioabsorbable stent and method of making the same |
US5059211A (en) | 1987-06-25 | 1991-10-22 | Duke University | Absorbable vascular stent |
US5176908A (en) | 1988-12-19 | 1993-01-05 | American Cyanamid Company | Method for the treatment of endotoxic shock in mammal |
US4990155A (en) | 1989-05-19 | 1991-02-05 | Wilkoff Howard M | Surgical stent method and apparatus |
US5100899A (en) | 1989-06-06 | 1992-03-31 | Roy Calne | Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof |
CA2049973C (en) | 1990-02-28 | 2002-12-24 | Rodney G. Wolff | Intralumenal drug eluting prosthesis |
US5545208A (en) | 1990-02-28 | 1996-08-13 | Medtronic, Inc. | Intralumenal drug eluting prosthesis |
AU7998091A (en) | 1990-05-17 | 1991-12-10 | Harbor Medical Devices, Inc. | Medical device polymer |
US5258020A (en) * | 1990-09-14 | 1993-11-02 | Michael Froix | Method of using expandable polymeric stent with memory |
DE69131423T2 (en) | 1991-03-08 | 2000-01-20 | Keiji Igaki | STENT FOR VESSELS, BRACKET STRUCTURE FOR THIS STENT AND DEVICE FOR ASSEMBLING THE SAME |
US5120842A (en) | 1991-04-01 | 1992-06-09 | American Home Products Corporation | Silyl ethers of rapamycin |
US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5151413A (en) | 1991-11-06 | 1992-09-29 | American Home Products Corporation | Rapamycin acetals as immunosuppressant and antifungal agents |
US5516781A (en) * | 1992-01-09 | 1996-05-14 | American Home Products Corporation | Method of treating restenosis with rapamycin |
CA2086642C (en) | 1992-01-09 | 2004-06-15 | Randall E. Morris | Method of treating hyperproliferative vascular disease |
US6013853A (en) | 1992-02-14 | 2000-01-11 | The University Of Texas System | Continuous release polymeric implant carrier |
US5288711A (en) | 1992-04-28 | 1994-02-22 | American Home Products Corporation | Method of treating hyperproliferative vascular disease |
US5540712A (en) | 1992-05-01 | 1996-07-30 | Nitinol Medical Technologies, Inc. | Stent and method and apparatus for forming and delivering the same |
GB9221220D0 (en) | 1992-10-09 | 1992-11-25 | Sandoz Ag | Organic componds |
US5258389A (en) | 1992-11-09 | 1993-11-02 | Merck & Co., Inc. | O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives |
US5342348A (en) | 1992-12-04 | 1994-08-30 | Kaplan Aaron V | Method and device for treating and enlarging body lumens |
US5443458A (en) | 1992-12-22 | 1995-08-22 | Advanced Cardiovascular Systems, Inc. | Multilayered biodegradable stent and method of manufacture |
US6663881B2 (en) * | 1993-01-28 | 2003-12-16 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
DE4303181A1 (en) | 1993-02-04 | 1994-08-11 | Angiomed Ag | Implantable catheter |
US5252579A (en) | 1993-02-16 | 1993-10-12 | American Home Products Corporation | Macrocyclic immunomodulators |
US5464650A (en) * | 1993-04-26 | 1995-11-07 | Medtronic, Inc. | Intravascular stent and method |
US5824048A (en) | 1993-04-26 | 1998-10-20 | Medtronic, Inc. | Method for delivering a therapeutic substance to a body lumen |
CN1046944C (en) * | 1993-12-17 | 1999-12-01 | 山道士有限公司 | Rapamycin derivatives useful as immunosuppressants |
US5362718A (en) | 1994-04-18 | 1994-11-08 | American Home Products Corporation | Rapamycin hydroxyesters |
US5649977A (en) * | 1994-09-22 | 1997-07-22 | Advanced Cardiovascular Systems, Inc. | Metal reinforced polymer stent |
WO1996011720A1 (en) | 1994-10-17 | 1996-04-25 | Kabushikikaisha Igaki Iryo Sekkei | Drug-releasing stent |
US5707385A (en) | 1994-11-16 | 1998-01-13 | Advanced Cardiovascular Systems, Inc. | Drug loaded elastic membrane and method for delivery |
US5565772A (en) | 1994-11-30 | 1996-10-15 | Eastman Kodak Company | High sensitivity magnetic viewer using anhysteretic transfer for viewing weak magnetic patterns |
US6231600B1 (en) | 1995-02-22 | 2001-05-15 | Scimed Life Systems, Inc. | Stents with hybrid coating for medical devices |
US6179817B1 (en) | 1995-02-22 | 2001-01-30 | Boston Scientific Corporation | Hybrid coating for medical devices |
US5869127A (en) | 1995-02-22 | 1999-02-09 | Boston Scientific Corporation | Method of providing a substrate with a bio-active/biocompatible coating |
US6099562A (en) | 1996-06-13 | 2000-08-08 | Schneider (Usa) Inc. | Drug coating with topcoat |
US5837313A (en) | 1995-04-19 | 1998-11-17 | Schneider (Usa) Inc | Drug release stent coating process |
US6120536A (en) | 1995-04-19 | 2000-09-19 | Schneider (Usa) Inc. | Medical devices with long term non-thrombogenic coatings |
CA2178541C (en) | 1995-06-07 | 2009-11-24 | Neal E. Fearnot | Implantable medical device |
US5609629A (en) * | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
BE1009856A5 (en) | 1995-07-14 | 1997-10-07 | Sandoz Sa | Pharmaceutical composition in the form of a solid release including macrolide and a vehicle. |
GB9606452D0 (en) | 1996-03-27 | 1996-06-05 | Sandoz Ltd | Organic compounds |
EP1006938A4 (en) * | 1996-04-08 | 2000-07-05 | Iowa India Investments Company | Multiple interconnected stents and method of coating stents |
CA2261666C (en) | 1996-07-30 | 2010-09-14 | Novartis Ag | Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin |
US6174329B1 (en) * | 1996-08-22 | 2001-01-16 | Advanced Cardiovascular Systems, Inc. | Protective coating for a stent with intermediate radiopaque coating |
US5980972A (en) | 1996-12-20 | 1999-11-09 | Schneider (Usa) Inc | Method of applying drug-release coatings |
KR100526913B1 (en) | 1997-02-20 | 2005-11-09 | 쿡 인코포레이티드 | Coated implantable medical device |
US5879697A (en) | 1997-04-30 | 1999-03-09 | Schneider Usa Inc | Drug-releasing coatings for medical devices |
US6670398B2 (en) * | 1997-05-14 | 2003-12-30 | Atherogenics, Inc. | Compounds and methods for treating transplant rejection |
WO1998057671A2 (en) * | 1997-06-18 | 1998-12-23 | Boston Scientific Corporation | Polycarbonate-polyurethane dispersions for thrombo-resistant coatings |
US6174330B1 (en) * | 1997-08-01 | 2001-01-16 | Schneider (Usa) Inc | Bioabsorbable marker having radiopaque constituents |
WO1999007308A1 (en) * | 1997-08-08 | 1999-02-18 | Sunscope International, Inc. | Microporous stent and implantation device |
US6159488A (en) | 1997-08-14 | 2000-12-12 | Agricultural Research Org. Ministry Of Agriculture (Gov.) | Intracoronary stents containing quinazolinone derivatives |
US6042606A (en) | 1997-09-29 | 2000-03-28 | Cook Incorporated | Radially expandable non-axially contracting surgical stent |
US6129755A (en) | 1998-01-09 | 2000-10-10 | Nitinol Development Corporation | Intravascular stent having an improved strut configuration |
US6190406B1 (en) | 1998-01-09 | 2001-02-20 | Nitinal Development Corporation | Intravascular stent having tapered struts |
US7208011B2 (en) * | 2001-08-20 | 2007-04-24 | Conor Medsystems, Inc. | Implantable medical device with drug filled holes |
US20010029351A1 (en) | 1998-04-16 | 2001-10-11 | Robert Falotico | Drug combinations and delivery devices for the prevention and treatment of vascular disease |
ATE466603T1 (en) | 1998-04-27 | 2010-05-15 | Surmodics Inc | BIOACTIVE ACTIVE COATINGS |
US6153252A (en) * | 1998-06-30 | 2000-11-28 | Ethicon, Inc. | Process for coating stents |
US20020038146A1 (en) * | 1998-07-29 | 2002-03-28 | Ulf Harry | Expandable stent with relief cuts for carrying medicines and other materials |
US6299604B1 (en) | 1998-08-20 | 2001-10-09 | Cook Incorporated | Coated implantable medical device |
US6335029B1 (en) | 1998-08-28 | 2002-01-01 | Scimed Life Systems, Inc. | Polymeric coatings for controlled delivery of active agents |
WO2000015763A1 (en) | 1998-09-14 | 2000-03-23 | Vesifact Ag | Utilization of nanocells in final culture medium products |
WO2000045763A1 (en) | 1999-02-02 | 2000-08-10 | The Procter & Gamble Company | Elastic laminate including spunbonded nonwoven of polypropylene/polyethylene copolymer and disposable article using the same |
US6607598B2 (en) * | 1999-04-19 | 2003-08-19 | Scimed Life Systems, Inc. | Device for protecting medical devices during a coating process |
US6368658B1 (en) * | 1999-04-19 | 2002-04-09 | Scimed Life Systems, Inc. | Coating medical devices using air suspension |
AU783158B2 (en) * | 1999-08-24 | 2005-09-29 | Ariad Pharmaceuticals, Inc. | 28-epirapalogs |
US6790228B2 (en) * | 1999-12-23 | 2004-09-14 | Advanced Cardiovascular Systems, Inc. | Coating for implantable devices and a method of forming the same |
US6713119B2 (en) | 1999-09-03 | 2004-03-30 | Advanced Cardiovascular Systems, Inc. | Biocompatible coating for a prosthesis and a method of forming the same |
US6277983B1 (en) | 2000-09-27 | 2001-08-21 | American Home Products Corporation | Regioselective synthesis of rapamycin derivatives |
IL133312A (en) | 1999-12-05 | 2006-09-05 | Orbotech Ltd | Method for printed circuit board inspection |
AU2292901A (en) * | 1999-12-23 | 2001-07-03 | Combe International Ltd. | Dental adhesive device and method for producing same |
EP2298299A3 (en) * | 2000-01-14 | 2012-02-29 | The Trustees Of The University Of Pennsylvania | O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
US7220276B1 (en) * | 2000-03-06 | 2007-05-22 | Surmodics, Inc. | Endovascular graft coatings |
ATE317709T1 (en) * | 2000-05-16 | 2006-03-15 | Ortho Mcneil Pharm Inc | METHOD FOR COATING MEDICAL DEVICES USING SUPERCRITICAL CARBON DIOXIDE |
US6569191B1 (en) * | 2000-07-27 | 2003-05-27 | Bionx Implants, Inc. | Self-expanding stent with enhanced radial expansion and shape memory |
DE10046448A1 (en) * | 2000-09-18 | 2002-03-28 | Daimler Chrysler Ag | Determining instantaneous engine crankshaft torque, measures work carried out in each cylinder in induction, compression, combustion and ejection stages |
WO2002026162A2 (en) * | 2000-09-26 | 2002-04-04 | Advanced Cardiovascular Systems, Inc. | A method of loading a substance onto an implantable device |
US6746773B2 (en) | 2000-09-29 | 2004-06-08 | Ethicon, Inc. | Coatings for medical devices |
AU1129902A (en) * | 2000-09-29 | 2002-04-08 | Cordis Corp | Coated medical devices |
US20020111590A1 (en) * | 2000-09-29 | 2002-08-15 | Davila Luis A. | Medical devices, drug coatings and methods for maintaining the drug coatings thereon |
US20020051730A1 (en) * | 2000-09-29 | 2002-05-02 | Stanko Bodnar | Coated medical devices and sterilization thereof |
US6863685B2 (en) | 2001-03-29 | 2005-03-08 | Cordis Corporation | Radiopacity intraluminal medical device |
ATE387169T1 (en) * | 2000-10-16 | 2008-03-15 | Conor Medsystems Inc | EXPANDABLE MEDICAL DEVICE FOR DELIVERING A MEDICINE |
US7077859B2 (en) * | 2000-12-22 | 2006-07-18 | Avantec Vascular Corporation | Apparatus and methods for variably controlled substance delivery from implanted prostheses |
US20020082679A1 (en) * | 2000-12-22 | 2002-06-27 | Avantec Vascular Corporation | Delivery or therapeutic capable agents |
US20030050692A1 (en) * | 2000-12-22 | 2003-03-13 | Avantec Vascular Corporation | Delivery of therapeutic capable agents |
US7083642B2 (en) * | 2000-12-22 | 2006-08-01 | Avantec Vascular Corporation | Delivery of therapeutic capable agents |
US20030033007A1 (en) * | 2000-12-22 | 2003-02-13 | Avantec Vascular Corporation | Methods and devices for delivery of therapeutic capable agents with variable release profile |
US7247338B2 (en) * | 2001-05-16 | 2007-07-24 | Regents Of The University Of Minnesota | Coating medical devices |
US6641611B2 (en) * | 2001-11-26 | 2003-11-04 | Swaminathan Jayaraman | Therapeutic coating for an intravascular implant |
WO2003035135A1 (en) * | 2001-09-24 | 2003-05-01 | Boston Scientific Limited | Optimized dosing for drug coated stents |
US20030077310A1 (en) * | 2001-10-22 | 2003-04-24 | Chandrashekhar Pathak | Stent coatings containing HMG-CoA reductase inhibitors |
US8740973B2 (en) * | 2001-10-26 | 2014-06-03 | Icon Medical Corp. | Polymer biodegradable medical device |
US7179283B2 (en) | 2001-11-02 | 2007-02-20 | Scimed Life Systems, Inc. | Vapor deposition process for producing a stent-graft and a stent-graft produced therefrom |
US20030088307A1 (en) * | 2001-11-05 | 2003-05-08 | Shulze John E. | Potent coatings for stents |
US6939376B2 (en) * | 2001-11-05 | 2005-09-06 | Sun Biomedical, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
US7682387B2 (en) | 2002-04-24 | 2010-03-23 | Biosensors International Group, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
US6743463B2 (en) * | 2002-03-28 | 2004-06-01 | Scimed Life Systems, Inc. | Method for spray-coating a medical device having a tubular wall such as a stent |
US20040024450A1 (en) * | 2002-04-24 | 2004-02-05 | Sun Biomedical, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
US7294145B2 (en) * | 2004-02-26 | 2007-11-13 | Boston Scientific Scimed, Inc. | Stent with differently coated inside and outside surfaces |
-
2002
- 2002-04-24 US US10/133,814 patent/US6939376B2/en not_active Expired - Lifetime
-
2003
- 2003-03-05 US US10/382,429 patent/US20030225450A1/en not_active Abandoned
- 2003-04-24 ES ES03747310.5T patent/ES2522277T3/en not_active Expired - Lifetime
- 2003-04-24 EP EP10185483.4A patent/EP2316377B1/en not_active Revoked
- 2003-04-24 JP JP2003587323A patent/JP4315817B2/en not_active Expired - Lifetime
- 2003-04-24 ES ES04078429T patent/ES2335406T3/en not_active Expired - Lifetime
- 2003-04-24 EP EP03747310.5A patent/EP1505930B1/en not_active Expired - Lifetime
- 2003-04-24 EP EP11185222.4A patent/EP2417943B1/en not_active Revoked
- 2003-04-24 CN CN2010102003218A patent/CN101862233B/en not_active Expired - Lifetime
- 2003-04-24 AU AU2003231759A patent/AU2003231759B2/en not_active Expired
- 2003-04-24 CN CN038093111A patent/CN1649551B/en not_active Expired - Lifetime
- 2003-04-24 WO PCT/US2003/012746 patent/WO2003090684A2/en active Application Filing
- 2003-04-24 EP EP12191560.7A patent/EP2578186B1/en not_active Revoked
- 2003-04-24 EP EP04078429A patent/EP1518517B1/en not_active Expired - Lifetime
- 2003-04-24 ES ES12191560.7T patent/ES2514391T3/en not_active Expired - Lifetime
- 2003-04-24 WO PCT/US2003/012750 patent/WO2003090818A2/en active Application Filing
- 2003-04-24 AU AU2003231757A patent/AU2003231757B2/en not_active Expired
- 2003-04-24 JP JP2003587443A patent/JP2005523119A/en active Pending
- 2003-04-24 CN CNA03809309XA patent/CN1735402A/en active Pending
- 2003-04-24 AT AT04078429T patent/ATE451075T1/en not_active IP Right Cessation
- 2003-04-24 EP EP09160438A patent/EP2113230A3/en not_active Withdrawn
- 2003-04-24 ES ES10185483.4T patent/ES2523870T3/en not_active Expired - Lifetime
- 2003-04-24 DE DE60330455T patent/DE60330455D1/en not_active Expired - Lifetime
-
2004
- 2004-09-20 US US10/946,275 patent/US7727275B2/en active Active
-
2008
- 2008-08-15 JP JP2008209129A patent/JP5113667B2/en not_active Expired - Lifetime
- 2008-08-15 JP JP2008209130A patent/JP2008279278A/en active Pending
-
2009
- 2009-04-27 AU AU2009201655A patent/AU2009201655B2/en not_active Expired
-
2010
- 2010-01-29 US US12/696,318 patent/US8308795B2/en not_active Expired - Lifetime
- 2010-04-29 HK HK13104941.7A patent/HK1177882A1/en not_active IP Right Cessation
- 2010-04-29 HK HK11110804A patent/HK1156494A1/en not_active IP Right Cessation
-
2011
- 2011-04-20 HK HK11104004.3A patent/HK1150229A1/en not_active IP Right Cessation
-
2012
- 2012-10-09 US US13/647,977 patent/US8715341B2/en not_active Expired - Lifetime
- 2012-12-17 JP JP2012274329A patent/JP2013121509A/en active Pending
-
2014
- 2014-02-20 JP JP2014030790A patent/JP5827355B2/en not_active Expired - Lifetime
- 2014-03-18 US US14/217,948 patent/US20140200654A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6273913B1 (en) * | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
US6585764B2 (en) * | 1997-04-18 | 2003-07-01 | Cordis Corporation | Stent with therapeutically active dosage of rapamycin coated thereon |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003090684A3 (en) | Polymer compositions containing a macrocyclic triene compound | |
WO2005060972A3 (en) | Pyrrolo [2,3-d] pyrimidine compounds for treating transplant rejection | |
NZ609344A (en) | Method for treatment of diarrhea-predominant irritable bowel syndrome | |
WO2006062857A3 (en) | Compositions having a high antiviral and antibacterial efficacy | |
WO2006066109A3 (en) | Hydroxysteroid dehydrogenase inhibitors | |
WO2006126081A3 (en) | Pyridino [2 , 3-b] pyrazinones as pde-5 inhibitors | |
MXPA03012013A (en) | Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain. | |
WO2006105127A3 (en) | Hydroxysteroid dehydrogenase inhibitors | |
EP2308877A4 (en) | Imidazopyridin-2-on derivative | |
WO2004062613A3 (en) | Hiv integrase inhibitors | |
EP2457913A3 (en) | Heteroaryl compounds, compositions thereof, and methods of treatment therewith | |
WO2005066163A3 (en) | Thiophene derivatives as chk 1 inihibitors | |
WO2006073457A3 (en) | Bioactive compounds and methods of uses thereof | |
EP1584235A3 (en) | Antibacterial composition containing a metal complexed with a polymer | |
WO2006037335A3 (en) | Use of compounds for the prevention of drug-induced cell toxicity | |
TNSN05320A1 (en) | Pyrido` 2, 1-a - isoquinoline derivatives as dpp-iv inhibitors | |
WO2006126082A3 (en) | Pyridine [3,4-b] pyrazinones as pde-5 inhibitors | |
WO2008003978A3 (en) | Dioxo-alkanes and dioxo-alkenes | |
AU2003218110A1 (en) | C3-cyano epothilone derivatives | |
WO2008103847A3 (en) | Bridged polycyclic compound based compositions for the inhibition and amelioration of disease | |
PL1730144T3 (en) | Substituted 1,4,8-triazaspiro¬4.5 decan-2-one compounds | |
WO2003059900A1 (en) | Coumarin derivatives, process for their production and use thereof | |
WO2004084876A3 (en) | Use of compounds for the prevention of drug-induced cell toxicity | |
TW200639153A (en) | Prevention of bacterial contamination | |
WO2004009030A3 (en) | Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
B | Later publication of amended claims |
Effective date: 20031212 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003587323 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003809309X Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003231757 Country of ref document: AU |
|
CFP | Corrected version of a pamphlet front page |
Free format text: UNDER (54) PUBLISHED TITLE REPLACED BY CORRECT TITLE |
|
122 | Ep: pct application non-entry in european phase |